An Efficacy and Safety Study of Infliximab in Participants With Rheumatoid Arthritis
Status:
Completed
Trial end date:
2008-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effectiveness of iInfliximab plus methotrexate
(MTX) in treatment of Rheumatoid rheumatoid Arthritis arthritis (RA) (it is an autoimmune
disease that causes pain, swelling, stiffness and loss of function in joints) in participants
with moderate disease versus participants with severe disease and to compare the efficacy and
safety of the MTX subgroups.